Lifeward (LFWD) Operating Income Growth (3y) (2018 - 2026)

Lifeward (LFWD) Operating Income Growth (3y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (3y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -3.76%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 8.39%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 6.17%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 25.88%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 7.13%
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 75.54%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 34.83%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -2.70%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Lifeward 8.16 Mn -3.26 Mn 1.34 Mn -33.20%

Historic Data

Download Data
DateValue
Mar 31, 2026 -33.20%
Dec 31, 2025 -0.75%
Sep 30, 2025 16.70%
Jun 30, 2025 -14.47%
Mar 31, 2025 -4.21%
Dec 31, 2024 -58.41%
Sep 30, 2024 -6.04%
Jun 30, 2024 -12.25%
Mar 31, 2024 -29.11%
Dec 31, 2023 -30.19%
Sep 30, 2023 -37.29%
Jun 30, 2023 -26.43%
Mar 31, 2023 -6.70%
Dec 31, 2022 -15.99%
Sep 30, 2022 -21.47%
Jun 30, 2022 -1.10%
Mar 31, 2022 -6.25%
Dec 31, 2021 1.21%
Sep 30, 2021 13.57%
Jun 30, 2021 15.88%